The authors have disclosed that they have no financial interests, arrangements, affiliations, or commercial interests with the manufacturers of any products discussed in this article or their competitors. Dr. Rhoads’ effort on this project was supported by a Harold Amos Medical Faculty Development Award from the Robert Wood Johnson Foundation, Princeton, NJ, and the National Cancer Institute (1R21CA161786-01A1).
Hewitt ME, Simone JV, eds; National Cancer Policy Board, Institute of Medicine and National Research Council. Ensuring Quality Cancer Care. Washington, DC: National Academies Press; 1999.
Merkow RP, Bilimoria KY. Currently available quality improvement initiatives in surgical oncology. Surg Oncol Clin N Am 2012;21:367–375, vii.
Birkmeyer JD, Dimick JB, Birkmeyer NJ. Measuring the quality of surgical care: structure, process, or outcomes? J Am Coll Surg 2004;198:626–632.
Brouwers MC, Kho ME, Browman GP et al.. AGREE II: advancing guideline development, reporting and evaluation in health care. J Clin Epidemiol 2010;63:1308–1311.
Bilimoria KY, Talamonti MS, Wayne JD et al.. Effect of hospital type and volume on lymph node evaluation for gastric and pancreatic cancer. Arch Surg 2008;143:671–678; discussion 678.
Greenberg CC, Lipsitz SR, Neville B et al.. Receipt of appropriate surgical care for Medicare beneficiaries with cancer. Arch Surg 2011;146:1128–1134.
Merkow RP, Bilimoria KY, Chow WB et al.. Variation in lymph node examination after esophagectomy for cancer in the United States. Arch Surg 2012;147:505–511.
Dikken JL, Stiekema J, van de Velde CJ et al.. Quality of care indicators for the surgical treatment of gastric cancer: a systematic review. Ann Surg Oncol 2013;20:381–398.
Verlato G, Roviello F, Marchet A et al.. Indexes of surgical quality in gastric cancer surgery: experience of an Italian network. Ann Surg Oncol 2009;16:594–602.
Jensen LS, Nielsen H, Mortensen PB et al.. Enforcing centralization for gastric cancer in Denmark. Eur J Surg Oncol 2010;36(Suppl 1):S50–54.
Harris DH, Allen ME, Snipes KP. Research Utilizing the California Cancer Registry, July 2007. Sacramento, CA: California Department of Public Health, Cancer Surveillance Section; 2007.
Yost K, Perkins C, Cohen R et al.. Socioeconomic status and breast cancer incidence in California for different race/ethnic groups. Cancer Causes Control 2001;12:703–711.
Yost KJ, Hahn EA, Zaslavsky AM et al.. Predictors of health-related quality of life in patients with colorectal cancer. Health Qual Life Outcomes 2008;6:66.
Visser BC, Ma Y, Zak Y et al.. Failure to comply with NCCN Guidelines for the management of pancreatic cancer compromises outcomes. HPB (Oxford) 2012;14:539–547.
NCCN Clinical Practice Guidelines in Oncology for Gastric Cancer. Version 1, 2000 (obtained on request from NCCN). To view the most recent version of these guidelines, visit NCCN.org.
Charlson ME, Pompei P, Ales KL et al.. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373–383.
Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992;45:613–619.
Siegel R, Ward E, Brawley O et al.. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 2011;61:212–236.
Macdonald JS, Smalley SR, Benedetti J et al.. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 2001;345:725–730.
Erickson Foster J, Velasco JM, Hieken TJ. Adverse outcomes associated with noncompliance with melanoma treatment guidelines. Ann Surg Oncol 2008;15:2395–2402.
Bristow RE, Powell MA, Al-Hammadi N et al.. Disparities in ovarian cancer care quality and survival according to race and socioeconomic status. J Natl Cancer Inst 2013;105:823–832.
Albright HW, Moreno M, Feeley TW et al.. The implications of the 2010 Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act on cancer care delivery. Cancer 2011;117:1564–1574.
Keegan KA, Penson DF. The Patient Protection and Affordable Care Act: the impact on urologic cancer care. Urol Oncol 2013;31:980–984.
National Quality Forum Web site. Available at: http://www.qualityforum. org/Home.aspx. Accessed February 6, 2015.
Davies J, Chalmers AG, Sue-Ling HM et al.. Spiral computed tomography and operative staging of gastric carcinoma: a comparison with histopathological staging. Gut 1997;41:314–319.
Bunt AM, Hermans J, Smit VT et al.. Surgical/pathologic-stage migration confounds comparisons of gastric cancer survival rates between Japan and Western countries. J Clin Oncol 1995;13:19–25.
McGhan LJ, Pockaj BA, Gray RJ et al.. Validation of the updated 7th edition AJCC TNM staging criteria for gastric adenocarcinoma. J Gastrointest Surg 2012;16:53–61; discussion 61.
Cunningham D, Allum WH, Stenning SP et al.. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 2006;355:11–20.
Walter LC, Davidowitz NP, Heineken PA et al.. Pitfalls of converting practice guidelines into quality measures: lessons learned from a VA performance measure. JAMA 2004;291:2466–2470.